RJ
Rajesh Jat
About Rajesh Jat
Data last updated:
Rajesh Jat is a Director at Wilburt Remedies Private Limited (since 2012), Director at Wilshire Pharmaceuticals Private Limited (since 2010) and Director at Willcare Lifesciences Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Trading and Agriculture. The 3 current companies with reported revenue have a combined latest revenue of ₹46.84 Cr; the largest is Wilburt Remedies Private Limited at ₹18.35 Cr (FY 2023). Earlier, Rajesh Jat was a Director at Wilshire Pesticides & Fertilizer Private Limited (2012–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 May 2012 | 2012 | ₹18.35 Cr (FY 2023) | Active | |
| Director | 08 Sep 2010 | 2010 | ₹15.58 Cr (FY 2023) | Active | |
| Director | 14 Apr 2023 | 2011 | ₹12.91 Cr (FY 2025) | Active | |
| Director | 06 Sep 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Oct 2012 | 2012 | ₹30.07 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Jat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharamveer Singh Shaktawat | 06923143 | Wilburt Remedies Private Limited | Director |
| Pramod Patil | 03146744 | Wilburt Remedies Private Limited , Wilshire Pharmaceuticals Private Limited and 1 more | Director |
| Prashant Singh | 03303106 | Wilburt Remedies Private Limited , Wilshire Pharmaceuticals Private Limited and 1 more | Director |
| Mohd Arif Siddique | 03136684 | Wilshire Pharmaceuticals Private Limited | Director |
| Mohd Kamil Shah | 03343494 | Wilshire Pharmaceuticals Private Limited | Director |
| Gururaj Patil | 11338821 | Willcare Lifesciences Private Limited | Additional Director |
| Prashant Srikanti | 03535756 | Willcare Lifesciences Private Limited | Director |
| Ravi Sood | 03619759 | Willcare Lifesciences Private Limited | Director |
| Shashank Bajpai | 06437181 | Willcare Lifesciences Private Limited | Director |
| Harsh Khandelwal | 10770748 | Wilburt Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Jat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Jat
Rajesh Jat currently holds 4 directorships: Wilburt Remedies Private Limited (Director, since 25 May 2012, revenue ₹18.35 Cr (FY 2023)); Wilshire Pharmaceuticals Private Limited (Director, since 08 Sep 2010, revenue ₹15.58 Cr (FY 2023)); Willcare Lifesciences Private Limited (Director, since 14 Apr 2023, revenue ₹12.91 Cr (FY 2025)); Wilburt Pharmaceuticals Private Limited (Director, since 06 Sep 2024).
Rajesh Jat was first appointed on 08 Sep 2010 as Director at Wilshire Pharmaceuticals Private Limited. The most recent appointment on record is 06 Sep 2024 at Wilburt Pharmaceuticals Private Limited.
The 3 current companies of Rajesh Jat that report revenue have a combined latest revenue of ₹46.84 Cr: Wilburt Remedies Private Limited ₹18.35 Cr (FY 2023); Wilshire Pharmaceuticals Private Limited ₹15.58 Cr (FY 2023); Willcare Lifesciences Private Limited ₹12.91 Cr (FY 2025).
Rajesh Jat held 1 earlier board appointment: Wilshire Pesticides & Fertilizer Private Limited (Director, 16 Oct 2012 to 07 Dec 2017).
The current boards of Rajesh Jat's companies include Dharamveer Singh Shaktawat (Wilburt Remedies Private Limited), Pramod Patil (Wilburt Remedies Private Limited), Prashant Singh (Wilburt Remedies Private Limited), Mohd Arif Siddique (Wilshire Pharmaceuticals Private Limited), Mohd Kamil Shah (Wilshire Pharmaceuticals Private Limited), Gururaj Patil (Willcare Lifesciences Private Limited), among others.